Previous Article | Next Article 
Journal of Clinical Microbiology, September 2001, p. 3072-3079, Vol. 39, No. 9
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.9.3072-3079.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
PCR Detection and Molecular Identification of
Chlamydiaceae Species
J. C.
Hartley,1,*
S.
Kaye,2
S.
Stevenson,1
J.
Bennett,2 and
G.
Ridgway1
Department of Clinical Microbiology,
University College London Hospital NHS Trust, London WC1E
6DB,1 and Royal Free and University
College Medical School, Department of Virology, London W1T
4JF,2 United Kingdom
Received 16 November 2000/Returned for modification 18 December
2000/Accepted 21 May 2001
 |
ABSTRACT |
Recent taxonomic developments, based on 16s and 23s rRNA gene
sequences, have divided the family Chlamydiaceae
into two genera and nine species, of which five have been found to
infect humans. Few simple methods are available to detect and
identify all species sensitively and specifically. In this study the
suitability of the omp2 gene as a target for molecular
identification of Chlamydiaceae is demonstrated.
Phylogenetic analysis of partial omp2 gene sequences from
all nine species agrees with the recently published taxonomic changes
based on the ribosomal genes. The use of a family-specific PCR primer
pair, which is able to amplify the 5' end of the omp2 gene
from all Chlamydiaceae except some
Chlamydophila pecorum strains, is described. Identification
of all nine species was achieved using restriction fragment length
polymorphism analysis with a single enzyme, AluI, confirmed
by DNA sequencing. A PCR enzyme-linked oligonucleotide assay was
developed which can detect a single chlamydial genome and may be
applied to DNA extracts from any specimen or culture for the detection
of single or mixed human chlamydial infection.
 |
INTRODUCTION |
The family Chlamydiaceae
has recently been reclassified into two genera and nine species
(4). Current human infection by Chlamydiaceae
is frequently diagnosed as Chlamydia trachomatis, but less
frequently as Chlamydophila pneumoniae (formerly
Chlamydia pneumoniae), and rarely as Chlamydophila
psittaci (formerly Chlamydia psittaci avian group),
Chlamydophila abortus (formerly Chlamydia psittaci abortion group), or Chlamydophila felis
(formerly Chlamydia psittaci feline pneumonitis agent). No
observation has been made of human infection with Chlamydophila
caviae (formerly Chlamydia psittaci guinea pig
inclusion conjunctivitis agent), Chlamydophila pecorum
(formerly Chlamydia pecorum), Chlamydia suis
(formerly porcine Chlamydia trachomatis), or
Chlamydophila muridarum (formerly Chlamydia
trachomatis of mice).
Other than for C. trachomatis, laboratory diagnostic methods
are poorly developed and not standardized. Serology is commonly used for diagnosis (6, 15), but the immune response to
chlamydial infection is often delayed and variable.
Microimmunofluorescence, the reference serology method, which was
designed for the serotyping of C. trachomatis, is difficult
to perform and not fully standardized and does not always
correlate with cell culture or nucleic acid detection (8,
12, 15, 16, 20). Commercial reagents available for the detection
of Chlamydiaceae by direct immunofluorescence (DIF)
include the family-specific antibody against the
lipopolysaccharide (e.g., Imagen Chlamydia; Dako Diagnostica
GmbH, Hamburg, Germany) and a C. trachomatis-specific
antibody directed against the major outer membrane protein (MOMP)
(e.g., Syva Microtrak; Bearing Diagnostics Inc., Cupertino,
Calif.). Use of these antibodies in DIF for the detection of elementary
bodies (EBs) from clinical material requires skilled staff and is
subjective. Enzyme immunoassays for detection of chlamydial antigens
have been shown to be generally of modest sensitivity
(13).
Commercially available sensitive and specific nucleic acid
amplification tests are primarily designed for C. trachomatis (13). Specific in-house PCR assays have
been developed for other species (1, 10), but multiple or
multiplex PCRs are needed to screen specimens collected from sites that
are associated with infection by more than one species, such as
conjunctivae and the respiratory tract. In addition, most PCR-based
assays for the former C. psittaci group do not distinguish
the recently described species (10).
C. trachomatis may be isolated when cell culture is
available, but C. pneumoniae is difficult to culture, with
only two reported isolates from patients in the United Kingdom
(2). Other Chlamydophila species are more
easily isolated, when attempted, but require level 3 (P3)
containment facilities for their propagation. When a
Chlamydiaceae species is isolated by culture, there are few phenotypic methods available for determining the species
(17). Production of a glycogen vacuole and sensitivity to
sulfonamides have been used to identify Chlamydia spp.
Species-specific antisera have been produced but are not freely available.
Recent methods for typing chlamydiae have been based on DNA
sequencing. The new taxonomic description of the
Chlamydiaceae uses the 16s and 23s rRNA gene
sequences, and a typing system based on PCR and sequencing of the
rRNA genes has been proposed, although other genes may be suitable for
identification of species (4, 5, 18).
The omp2 gene of the Chlamydiaceae has two
conserved regions at the 5' end bordering a variable segment, and
primers designed to be complementary to these conserved regions have
been used to amplify the omp2 gene from many
Chlamydiaceae (18). The sequence variation has
been used to design species identification tests using the
omp2 PCR product, e.g., PCR-restriction fragment length polymorphism (PCR-RFLP) analysis and heminested PCR (14,
18) and agarose gel electrophoresis with
bisbenzimide-polyethylene glycol (PEG) (3). Although no
publications were found distinguishing all the current species,
PCR-RFLP patterns after digestion with AluI do produce
characteristic patterns for six species (3, 14), but no
published patterns have been observed for C. felis, C. muridarum, or C. suis.
The purpose of this work was to determine whether a sensitive and
species-specific PCR-enzyme-linked oligonucleotide assay (PCR-ELONA)
and/or PCR-RFLP assay could be designed, based on the omp2
gene, which would be able to detect and identify any Chlamydiaceae sp. To confirm the suitability of the
omp2 gene as a target, partial omp2 gene
sequences were generated for the two species not previously sequenced
(C. felis and C. suis), and the taxonomic
relationship of all species was investigated by cluster analysis.
 |
MATERIALS AND METHODS |
Bacterial cultures and DNA extraction.
C.
pneumonia (IOL207, TW183, and V1355), C. trachomatis
(SA2F), C. muridarum (MoPn), and C. psittaci (Z10*) were grown in McCoy cell culture, and supernatants
were clarified by low-speed centrifugation (400 × g)
to produce suspensions of EBs. DNA was extracted by boiling. C. felis (FePn*) and C. pecorum (P787*, 11/88*, VR628*,
and R69*) were grown in McCoy cell culture and stored in cell culture
growth medium (minimal essential medium [MEM]). DNA was extracted by
the QIAamp blood kit protocol (Qiagen Ltd., Crawley, England) from
these isolates and from uninfected McCoy cells in MEM. C. suis S45* was obtained as an egg yolk sac preparation of EBs.
(Isolates originally provided by Garath Jones, Yaba Ltd., are marked
with an asterisk.) C. abortus (AB7) and C. caviae
(GPIC) cell culture supernatants were provided by P. Bavoil, London
School of Hygiene and Tropical Medicine. DNA was extracted by boiling
for 15 min and then diluted in water. C. caviae and C. suis boilates were further purified on a Qiagen spin column
(Qiagen Ltd.). Fourteen serotypes of C. trachomatis, A
(SA1), B (TW5), C (UW1), D (ICCa18), E (DK20), F (MRC301), G (IOL238),
H (UW4), I (UW12), J (UW36), K (UW31), L1 (440L), L2 (434B), and L3
(404L), were obtained as egg-grown formaldehyde-treated EB preparations
(originally from the Institute of Ophthalmology, London). Aliquots (5 µl) were diluted in 200 µl of water and boiled for 15 min.
PCR specificity was confirmed by cross-testing against previously
characterized DNA extracts from Mycoplasma pneumoniae,
Ureaplasma urealyticum, Staphylococcus
epidermidis, Streptococcus pneumoniae, Streptococcus agalactiae, Streptococcus
pyogenes, Streptococcus mitis, Stenotrophomonas
maltophilia, Burkholderia cepacia, Escherichia coli, and Neisseria meningitidis, provided by Kathryn
Harris, Great Ormond Street Hospital, London. Additionally, DNA was
extracted from boiled suspensions of pure cultures of Pseudomonas
aeruginosa, Listeria monocytogenes, Klebsiella
pneumoniae, Staphylococcus aureus, Haemophilus
influenzae, Moraxella catarrhalis, Shigella sonnei, Shigella flexneri, Vibrio
cholerae, Bacteroides fragilis, Salmonella
sp., Campylobacter jejeni, Clostridium
perfringens, Peptostreptococcus sp., Enterococcus
faecalis, Neisseria gonorrhoeae, and Candida
albicans.
Uncharacterized chlamydial isolates.
Two chlamydiae isolated
in the Chlamydia Laboratory, University College London Hospital, were
provided for analysis as cell culture supernatants. Culture
confirmation had been positive with the family-specific
antilipopolysaceharide antibody but negative with the C. trachomatis anti-MOMP antibody, confirming the presence of
Chlamydiaceae other than C. trachomatis. DNA was
extracted by boiling.
Production of enumerated suspensions of EBs of C. trachomatis and C. pneumoniae.
A suspension of
EBs (which are 0.2 to 0.4 µm in diameter) was prepared by a
differential filtration method. C. trachomatis SA2F (L2) and C. pneumoniae TW187 were
propagated in McCoy cells. An aliquot of fresh cell culture supernatant
was passed through a 0.45-µm filter (Minisart; Sartorius), and the
filtrate was retained. The filtrate was then passed through a 0.2-µm
filter (Minisart; Sartorius), followed by 10 ml of phosphate-buffered
saline (PBS), and the filter was back eluted with 5 ml of PBS to give a
purified EB suspension. The stock suspension was diluted in PBS,
counted, and stored in aliquots at
70°C. The concentration of EBs
was determined by counting of organisms stained with fluorescein
isothiocyanate-labeled anti-LPS antibody (Imagen Chlamydia) and by
endpoint dilution PCR. Quantification by endpoint dilution PCR was
performed by amplifying multiple replicates of each dilution of a
boiled suspension of EBs using the PCR and ELONA conditions described below.
PCR primer and probe design.
Primer and probe design was
based on alignment of published omp2 gene sequences
(sequence data for C. felis, C. muridarum, C. suis, and the primer-binding sites of C. pecorum was
not available initially). Primers were selected to allow the
amplification of all target species in a single reaction by identifying
conserved sequences in the omp2 gene. The primer sequences
selected, designated Ch1 and Ch2, were modified from ones described
previously (D1 and D2 in reference 18), although D2 was
also used. Family-specific and species-specific probes were designed
for use in a stringent ELONA. We have subsequently sequenced the
corresponding omp2 regions of C. felis (FePn) and
C. suis (S45), while C. muridarum (MoPn) and the
complete 3' end of C. pecorum strain W73 have since been submitted to GenBank.
Alignment of sequences from all nine species is shown in Fig.
1. Primer and probe sequences selected
are highlighted in Fig.
1 and shown in Table
1.

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 1.
Alignment of partial omp2 nucleotide
sequences from all nine species of Chlamydiaceae. Primer and
probe sequences and AluI restriction sites (motif AGCT) are
highlighted. Dashes represent areas of predicted DNA deletions.
(Initial alignment produced by submission to the ClustalW programme on
the European Bioinformatics Institute website.) Additional
sequences available: C. trachomatis, eight sequences
(GenBank loci CTOMP2, CHTOMPE, CHTOMPA, CHTCRPA, CTSL3CRP, CTSCCRP,
CHTOMP2A, and AE001317); C. pneumoniae, 10 sequences (8 in
reference 7, and genomes of AR39 and CW1029 in Genbank);
C. psittaci, 2 sequences (Genbank CPSCROMP and reference
14); C. abortus, 1 sequence (14);
C. pecorum, 4 partial sequences (U56927, AF111199, and
reference 14). All additional sequences show 98.5 to 100%
homology with the sequence shown above, with no alterations in
restriction sites; however, the 3' primer-binding site of C. pecorum strain VR268 (accession no. U56927) is altered at the
first 3 bases (TGG to GCC).
|
|
PCR conditions.
All reactions were carried out in a
Perkin-Elmer type 480 thermal cycler in 50µl reaction volumes.
Reactions contained 1 to 10 µl of processed sample, 200 µM each of
a mix of deoxynucleoside triphosphates (Amersham-Pharmacia), 5 pmol of
each primer, 5 µl of 10× buffer with 15 mM MgCl2 and
1.25 U of Taq or Taq Gold (used during specificity tests with
nonchlamydia isolates) polymerase (Roche Biochemicals). Standard
amplification conditions for primers Ch1 and Ch2 were 94°C for 4 min
(or 95°C for 10 min for Taq Gold) for 1 cycle; 94°C for 1 min,
55°C for 1 min, and 72°C for 1 min for 40 cycles; and a final
extension step of 72°C for 7 min for 1 cycle. Additional
amplifications were performed with Ch1/Ch2 and with primer pair Ch1/D2,
Taq Gold polymerase, and an annealing temperature of 45°C.
Chemiluminescent ELONA.
The ELONA method was that described
by Whitby and Garson (19). Briefly, 5 µl of the
biotinylated PCR product was captured on a streptavidin-coated
microtiter well. After capture and washing, the double-stranded DNA was
denatured by the addition of 0.15 M NaOH, and the second strand was
washed away. A specific enzyme-labeled oligonucleotide probe was then
hybridized to the captured antisense strand. Unbound label was removed
by washing, and bound label was detected with a chemiluminescent
substrate (Lumiphos; Lumigen Inc.). The final result is given as a
numerical value in counts per second (cps) produced by a Cunberra
Packard Top Count scintillation counter.
In a modified protocol designed to reduce the expense of synthesizing
multiple enzyme-labeled probes, unlabeled probes were
synthesized with
a common 3' tail sequence to which a complementary
enzyme-labeled
oligonucleotide could be annealed. Sequence details
are given in Table
1. After washing away the unbound probe, the
alkaline
phosphatase-labeled oligonucleotide AP-COM, diluted in
the same buffer
as the probe (see Whitby and Garson 1995 for details
[
19]), was added to the wells and incubated at 37°C
for 30 min
before washing and addition of substrate as with a directly
labeled
probe.
RFLP analysis.
A discriminatory restriction enzyme was
sought by analysis of cutting sites from available sequence data.
Restriction with AluI was predicted to give species-specific
band lengths, shown in Table 2. Digestion
was performed by incubating a 10-µl aliquot of PCR product with 1 U
of enzyme (Promega), 2 µl of 10× buffer, and 7 µl of water for
1 h at 37°C. The products were analyzed by electrophoresis on a
4% Metaphor gel (FMC Bioproducts, Rockland, Maine), stained with
ethidium bromide, and compared to the predicted analysis.
Sequencing.
Sequencing of C. felis (FePn),
C. suis (S45), C. psittaci (Z10), and unknown
isolate A was performed using primers Ch1 and Ch2 on PCR products
amplified from the omp2 gene and analyzed on an ABI 377 automated sequencer (Big Dye). Isolate B was sequenced using Texas
red-labeled Ch1 and Ch2 primers and analyzed on a Vistra 725 automated
sequencer (Amersham). Sequences have been submitted to GenBank.
C. felis and C. suis are shown within the sequence alignment (Fig. 1).
Phylogenetic analysis.
The corresponding partial
omp2 gene sequences available for all species (Fig. 1) were
cluster analyzed by using the ClustalW algorithm in the Megalign program.
 |
RESULTS |
PCR specificity.
PCR with primers Ch1 and Ch2 was performed on
DNA extracts of Chlamydiaceae species and analyzed on a 2%
agarose gel stained with ethidium bromide. With an annealing
temperature of 55°C, the primers amplified a single product band from
all species except C. pecorum; no visible bands were seen
from the four C. pecorum strains. At the lower annealing
temperature of 45°C, all chlamydial strains except C. pecorum VR628 were amplified, producing a band of the expected
length; however, an additional smaller band was produced with all four
extracts of C. pecorum and the uninfected McCoy cells in
FCM. Results are shown in Fig. 2.
Amplification with the primer pair Ch1/D2 at an annealing temperature
of 45°C yielded a single product of the expected length from all
species except C. pecorum VR628 (gel not shown), which
produced no visible product. CH1/D2 produced no product from any
C. pecorum at 55°C, although C. trachomatis L2
gave the expected omp2 product (gel not shown).

View larger version (69K):
[in this window]
[in a new window]
|
FIG. 2.
Gel electrophoresis of partial omp2 PCR
product from Chlamydiaceae. Lanes 1 and 16, size markers
( X174 HaeIII digest), with sizes (in base pairs) of
weight markers indicated at the right); lane 2, C. trachomatis serotype D; lane 3, C. trachomatis
serotype L2; lane 4, C. suis S45; lane 5, C. muridarum MoPn; lane 6, C. pneumoniae TW183; lane
7, C. pneumoniae V1355; lane 8, unidentified isolate A;
lane 9, C. psittaci Z10; lane 10, C. abortus AB7; lane 11, C. caviae GPIC; lane 12, C. felis FePn; lane 13, unidentified isolate B; lane
14, C. pecorum P787 (C. pecorum 11/88
and R69 also gave this pattern); lane 15, C. pecorum
VR628 (uninfected McCoy cells also gave this pattern). All
amplifications were performed with primers Ch1 and Ch2 with an
annealing temperature of 55°C except for the C. pecorum strains and uninfected McCoy cells, for which the
annealing temperature was 45°C.
|
|
Amplification of DNA extracts from other bacterial isolates listed,
using primers Ch1 and Ch2, Taq Gold, and an annealing
temperature of
55°C, yielded no detectable products by gel electrophoresis
or ELONA.
All extracts were shown not to be inhibitory by spiking
with
C. abortus DNA (gel not shown). DNA from
V. cholerae,
S. sonnei,
S. flexneri,
Bacteroides sp., and
Salmonella sp. gave
nonspecific
bands when amplified with
Taq (gel not
shown).
PCR-ELONA specificity.
All DNA extracts were amplified with
Ch1/Ch2 and an annealing temperature of 55°C and then probed in
parallel with three probes. The C. pecorum PCR products
from the lower annealing temperature reaction were also probed. ELONA
results are shown in Table 3. PCR
products from all Chlamydiaceae species, including
C. pecorum when amplified well, gave a strong signal
(100× background) with the family-specific probe (CfamP). The
species-specific probe for C. pneumoniae (CpnP)
specifically detected only this species. The C. trachomatis (CtraP) probe detected C. trachomatis,
C. muridarum, and, weakly, C. suis. The
signal strength for the family-specific probe used with C. trachomatis was lower than with the other species. Comparison
with the C. trachomatis species-specific probe
indicates that the signal reduction occurred during the ELONA, possibly due to the single-base mismatch (Fig. 1). The low CtraP signal for
C. suis (formerly C. trachomatis of
pigs) compared to the family-specific probe was explained by a
four-base difference in the gene sequence complementary to the probe.
Test of PCR sensitivity.
Absolute sensitivity was tested for
C. pneumoniae and C. trachomatis using
enumerated suspensions of EBs amplified with Ch1/Ch2 and an annealing
temperature of 55°C. The previously enumerated stock EB
suspensions were extracted by boiling for 15 min, and limiting-dilution
PCR was performed using a half-log dilution series in water. Each
dilution was amplified by PCR in up to four reactions, and
amplification was detected by ELONA. The results of the assay were also
used to determine a test/control ratio which enabled a cutoff ratio to
be assigned. An example of the ELONA results is shown in Table
4, showing the titration of a counted
suspension of C. pneumoniae EBs. ELONA titrations of
C. pneumoniae and C. trachomatis showed
that the method was able to detect a single input DNA target molecule
and show a positive/negative ratio for a single molecule of between 5 and 15.
Identification by omp2 PCR-RFLP.
The products from the
omp2 PCRs (C. pecorum was amplified at
45°C) were restriction digested with AluI as described in
Materials and Methods. The products of the digestion are shown in Fig.
3, demonstrating that the bands generated
correspond to the predicted sizes shown in Table 2 and are
characteristic for all nine species.

View larger version (87K):
[in this window]
[in a new window]
|
FIG. 3.
Gel electrophoresis of omp2 PCR products of
Chlamydiaceae after restriction digestion with
AluI. Lanes 1 and 16, size markers (as in Fig. 2); lane 2, C. trachomatis serotype D; lane 3, C. trachomatis serotype L2; lane 4, C. suis S45; lane
5, C. muridarum MoPn; lane 6, C. pneumoniae TW183; lane 7, C. pneumoniae V1355;
lane 8, unidentified isolate A; lane 9, C. psittaci
Z10; lane 10, C. abortus AB7; lane 11, C. caviae GPIC; lane 12, C. felis FePn; lane 13, unidentified isolate B; lane 14, C. pecorum P787
(C. pecorum 11/88 and R69 also gave this pattern); lane
15, C. pecorum VR628 (uninfected McCoy cells also gave
this pattern). All amplifications were performed with primers Ch1 and
Ch2 with an annealing temperature of 55°C except for the
C. pecorum strains and uninfected McCoy cells, for
which the annealing temperature was 45°C. The predicted sizes (in
base pairs) of the digest fragments are listed in Table 2.
|
|
Sequence of omp2 gene products of C. felis (FePn), C. suis (S45), and C. psittaci (Z10); sequence cluster analysis, taxonomic
classification, and species identification.
The newly
generated sequences of C. felis and
C. suis (GenBank accession nos. AF367407 and AF367408,
respectively) are shown aligned with the other Chlamydiaceae
in Fig. 1. C. psittaci Z10 sequencing produced a 536-bp
sequence identical to bases 29 to 564 of the C. psittaci sequence shown. The phylogenetic relationship of all
species based on the partial omp2 sequence clustering is shown in Fig. 4. The dendrogram produced
demonstrates the divergence between the designated species and mirrors
that derived by analysis of the rRNA sequences (4). The
similarity of the Z10 sequence to other C. psittaci
sequences demonstrates the conservation of the partial omp2
sequence within this species.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 4.
Unrooted tree of the omp2 sequences from
Chlamydiaceae species. Dendrogram produced using the
ClustalW algorithm in the Megalign program.
|
|
Uncharacterized chlamydial isolates.
The two nontrachomatis
isolates were analyzed by the PCR-ELONA and PCR-RFLP methods. Results
are shown in Table 3 and Fig. 3. In the ELONA, both isolates gave
strong signals with the family-specific probe (CgenP). Isolate A was
positive with the C. pneumoniae probe but not with the
C. trachomatis probe (CtraP), while isolate B was
negative with both of the specific probes used. The RFLP band pattern
of isolate A corresponded to that predicted for C. pneumoniae, and isolate B corresponded to C. felis. Isolate A sequencing produced a 536-bp sequence identical
to bases 29 to 564 of C. pneumoniae; the isolate B
sequence (GenBank AF367406) was 471 bp long and identical to the
corresponding C. felis sequence (bases 38 to 508 in
Fig. 1). DNA sequence analysis confirmed that isolate A is
C. pneumoniae and isolate B is C. felis.
 |
DISCUSSION |
Infection with chlamydiae other than C. trachomatis is often difficult to diagnose. Culture requires
special facilities, while the serological response is variable and the
tests are poorly standardized. Nucleic acid amplification tests are
being used more frequently (1, 10, 13, 15). However, the
majority of diagnostic tests are designed for C. trachomatis, and methods for the detection and identification to
species level of all nontrachomatis isolates are not readily available.
Recent taxonomic changes to the family were based on the 16s and 23s
rRNA genes; however, it may be possible to distinguish all species by
the detection of specific sequences within other genes. Outer membrane
protein 2 is an integral component of the cell wall of all chlamydiae, containing a variable N-terminal fragment which is species specific but
does not induce a species-specific humoral response (11). It had been shown that the 5' end of the gene for the Omp2 protein contains two short, highly conserved sequences suitable for use as
primer-binding sites for the amplification of many chlamydiae (3,
14, 18). We designed primers (Ch1 and Ch2) to target the same
conserved region. The product amplified from a single optimized PCR
could then be detected and identified by ELONA or RFLP designed around
the differences in the variable section, as long as these differences
were sufficient and conserved within a species.
Submitted sequence data (shown in Fig. 1) confirmed the highly
conserved nature of the primer-binding sequences for all species tested
except C. pecorum, for which variation was
revealed at the 3' end. C. pecorum W73 shows five
base changes within the 3' primer-binding site, while
C. pecorum VR268 has a complete mismatch at the
5' end of the 3' primer-binding site. As a result, primers CH1
and CH2, at an annealing temperature of 55°C, efficiently amplified
all Chlamydiaceae except C. pecorum. At
45°C, some strains of C. pecorum were also amplified.
With the sequencing of the 5' end of C. felis and C. suis, data are now available for the variable region in all nine
chlamydial species (Fig. 1). The nucleotide sequence between the primer
sites has been determined a number of times for some species. It is identical for all C. pneumoniae isolates
(7) and almost identical for C. trachomatis (eight GenBank accessions). Smaller numbers of the
other Chlamydophila spp. have been analyzed (listed in Fig.
1), and they also show a high degree of conservation of the partial
omp2 gene sequence within a species, as we have demonstrated with C. felis and C. psittaci.
Conservation may be maintained, as Omp2 does not induce a
species-specific humoral response (11). In contrast to the
conserved intraspecies sequence of omp2, alignment of the
sequences from all species demonstrates a high level of interspecies
divergence, with the same phylogenetic relationship to that produced by
alignment of the rRNA gene sequences (4). The
combination of interspecies variation with intraspecies conservation makes this locus a suitable candidate gene for the identification of
all nine species, including C. pecorum strains, when amplified.
The present study has used a PCR based on the family-specific primers
and combined the reaction with family- or species-specific oligonucleotide probes or with restriction digestion with a single enzyme, AluI, for the detection and identification of
Chlamydiaceae. The omp2 gene was originally
amplified with shorter primers, D1 and D2 (18), and an
annealing temperature of 45°C. We modified these primers to
provide better balance in a planned quantitative assay and to allow use
of a higher annealing temperature. Restriction digestion of the
partial omp2 gene PCR product with the enzyme AluI was shown to produce the predicted species-specific
patterns for all nine species. The PCR-RFLP is therefore able to
determine the species of isolates in agreement with the new taxonomic
classification. This was demonstrated with two unknown laboratory
isolates, which were shown to be strains of C. felis
and C. pneumoniae.
For use in clinical diagnosis, single-round reactions and analysis by
agarose gel electrophoresis may lack sensitivity and specificity.
Therefore, our PCR was combined with an ELONA using a chemiluminescent
substrate to provide family- or species-specific detection at high
sensitivity. The method can also be used for quantification
(19). Using suspensions of enumerated EBs of C. pneumoniae and C. trachomatis, the sensitivity of
the species-specific assay approached one genome copy input into
the PCR. The two species-specific hybridization probes designed
for C. pneumoniae and C. trachomatis were both specific and sensitive for chlamydiae infecting humans. The C. trachomatis probe also detected mouse and, less
sensitively, pig chlamydial infection. The PCR-ELONA as designed
classifies samples as containing chlamydial DNA using the
family-specific probe and as containing C. pneumoniae, C. trachomatis, or some other species
using the species-specific probes. Probes may be combined for
ease in a screening assay (data not shown), and additional species-specific probes could easily be incorporated into the method.
The format of a PCR-ELONA using a family-specific primer pair and
identification during the sensitive detection stage has other
advantages in addition to sensitivity and specificity. C. pneumoniae DNA has been shown to be difficult to recover from specimens, with up to 99% loss demonstrated during spiking experiments with various commercial and in-house procedures (9). The
addition of a known number of C. trachomatis EBs to the
specimen before extraction can be used as an internal control for all
stages of the assay, since the control and target can be
separately detected and quantified in the ELONA detection stage.
Furthermore, the chemiluminescent assay can be used to quantify the DNA
input either against an external calibration curve or through the
competitive quantitative PCR that occurs with the internal control
(unpublished data). In laboratories where a microtiter luminometer is
unavailable, colorimetric substrates may be substituted for the
chemiluminescent substrate used in the described method.
In conclusion, we have demonstrated that the omp2 gene of
Chlamydiaceae is a suitable locus to which molecular
detection and identification methods may be targeted. The alignment of
previously available and newly generated genome sequences confirmed the
taxonomic relationship between the newly described species within the
Chlamydiaceae family. The standard PCR-RFLP and
PCR-ELONA (annealing temperature of 55°C) were able to detect and
identify all previous and newly described species except C. pecorum. Reduction of the annealing temperature permitted
detection and identification of most C. pecorum
strains, but within-species variation in the 3' primer-binding site
prevents amplification of all strains. The combination of the
family-specific PCR with a chemiluminescent ELONA detection system
gives a highly sensitive and specific assay. The single optimized
method avoids the need for multiplex PCR, with its reduced sensitivity,
or for multiple PCRs, with their additional resource demand. This assay
has the potential to provide a simple and reliable means for the
detection and identification of Chlamydiaceae from clinical
specimens and cultures for the investigation of human chlamydial disease.
 |
ACKNOWLEDGMENT |
We thank K. Harris, Great Ormond Street Hospital, for performing
the cluster analysis.
 |
FOOTNOTES |
*
Corresponding author. Present address: Department of
Microbiology, Level 4, Camelia Botnar Laboratories, Great Ormond Street Hospital for Children NHS Trust, Great Ormond St., London WC1N 3JH,
United Kingdom. Phone: (0)20 7405 9200, ext. 5285. Fax: (0)20 7813 8268. E-mail: HartlJ3{at}gosh.nhs.uk.
 |
REFERENCES |
| 1.
|
Boman, J.,
C. A. Gaydos, and T. C. Quinn.
1999.
Molecular diagnosis of Chlamydia pneumonia infection.
J. Clin. Microbiol.
37:3791-3799[Free Full Text].
|
| 2.
|
Carter, M. W.,
T. G. Harrison,
M. Shuja Shafi, and R. C. George.
1998.
Typing strains of Chlamydia pneumoniae by AFLP.
Clin. Microbiol. Infect.
4:663-664[Medline].
|
| 3.
|
Demkin, V. V.,
M. V. Edelstein,
A. L. Zimin,
I. A. Edelstein, and M. M. Suvorov.
2000.
Detection of sequence variation in PCR-amplified fragments of omp2 gene from three species of the family Chlamydiaceae using agarose gel electrophoresis containing bisbenzimide-PEG.
FEMS Microbiol. Lett.
184:215-218[Medline].
|
| 4.
|
Everett, K. D. A.,
R. M. Bush, and A. A. Anderson.
1999.
Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms.
Int. J. Syst. Bacteriol.
49:415-440[Abstract/Free Full Text].
|
| 5.
|
Everett, K. D. A.,
L. J. Hornung, and A. A. Anderson.
1999.
Rapid detection of the Chlamydiaceae and other families in order Chlamydiales: three PCR tests.
J. Clin. Microbiol.
37:575-580[Abstract/Free Full Text].
|
| 6.
|
Freidank, H. N.,
H. Vögele, and K. Eckert.
1997.
Evaluation of a new commercial microimmunofluorescence test for detection of antibodies to Chlamydia pneumoniae, Chlamydia trachomatis, and Chlamydia psittaci.
Eur. J. Clin. Microbiol. Infect. Dis.
16:685-688[CrossRef][Medline].
|
| 7.
|
Jantos, C. A.,
S. Heck,
R. Roggendorf,
M. Sen-Gupta, and H. Hegemann.
1997.
Antigenic and molecular analyses of different Chlamydia pneumoniae strains.
J. Clin. Microbiol.
35:620-623[Abstract].
|
| 8.
|
Kutlin, A.,
P. M. Roblin, and M. R. Hammerschlag.
1998.
Antibody response to Chlamydia pneumoniae in children with respiratory illness.
J. Infect. Dis.
177:720-724[Medline].
|
| 9.
|
Lindholt, J. S.,
L. Ostergard,
E. W. Henneberg,
H. Fasting, and P. Anderson.
1998.
Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR).
Eur. J. Vasc. Endovasc. Surg.
15:161-164[CrossRef][Medline].
|
| 10.
|
Messmer, T. O.,
S. K. Skelton,
J. F. Moroney,
H. Daugharty, and B. S. Fields.
1997.
Application of a nested, multiplex PCR to psittacosis outbreaks.
J. Clin. Microbiol.
35:2043-2046[Abstract].
|
| 11.
|
Mygind, P.,
G. Christiansen,
K. Persson, and S. Birkelund.
1998.
Analysis of the humoral immune response to Chlamydia outer membrane protein 2.
Clin. Diagn. Lab. Immunol.
5:313-318[Abstract/Free Full Text].
|
| 12.
|
Persson, K., and S. Haidl.
2000.
Evaluation of a commercial test for antibodies to the chlamydial lipopolysaccharide (Medac) for serodiagnosis of acute infections by Chlamydia pneumoniae (TWAR) and Chlamydia psittaci.
APMIS
108:131-138[CrossRef][Medline].
|
| 13.
|
Schachter, J.
1999.
Which test is best for chlamydia?
Curr. Opin. Infect. Dis.
12:41-45.
|
| 14.
|
Sheehy, N.,
B. Markey,
M. Gleeson, and P. J. Quinn.
1996.
Differentiation of Chlamydia psittaci and C. pecorum strains by species-specific PCR.
J. Clin. Microbiol.
34:3175-3179[Abstract].
|
| 15.
|
Verkooyen, R. P.,
D. Willemse,
S. C. A. M. Hiepvan Casteren,
S. A. Mousave Joulandan,
R. J. Snijder,
J. M. M. van den Bosch, et al.
1998.
Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections.
J. Clin. Microbiol.
36:2301-2307[Abstract/Free Full Text].
|
| 16.
|
Wang, S. P.
2000.
The microimmunofluorescence test for Chlamydia pneumoniae infection: technique and interpretion.
J. Infect. Dis.
181(Suppl 3):S421-S425.
|
| 17.
|
Ward, M. E., and G. Ridgway.
1998.
Chlamydia, p. 1331-1346.
In
L. Collier, A. Balows, and M. Sussman (ed.), Topley and Wilson's microbiology and microbial infections, 9th ed. Arnold, New York, N.Y.
|
| 18.
|
Watson, M. W.,
P. R. Lambden, and I. N. Clarke.
1991.
Genetic diversity and identification of human infection by amplification of chlamydial 60-kilodalton cysteine-rich outer membrane protein gene.
J. Clin. Microbiol.
29:1188-1193[Abstract/Free Full Text].
|
| 19.
|
Whitby, K., and J. A. Garson.
1995.
Optimisation and evaluation of a quantitative chemiluminescent polymerase chain reaction assay for hepatitis C virus RNA.
J. Virol. Methods
51:75-88[CrossRef][Medline].
|
| 20.
|
Wong, Y. K.,
J. M. Sueur,
C. H. Fall,
J. Orfila, and M. E. Ward.
1999.
The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae.
J. Clin. Pathol.
52:99-102[Abstract].
|
Journal of Clinical Microbiology, September 2001, p. 3072-3079, Vol. 39, No. 9
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.9.3072-3079.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Petit, T., Spergser, J., Aurich, J., Rosengarten, R.
(2008). Examination of semen from bulls at five Austrian artificial insemination centres for chlamydiae and mollicutes. Vet Rec.
162: 792-793
[Full Text]
-
Aguirre, A. A., Keefe, T. J., Reif, J. S., Kashinsky, L., Yochem, P. K., Saliki, J. T., Stott, J. L., Goldstein, T., Dubey, J. P., Braun, R., Antonelis, G.
(2007). INFECTIOUS DISEASE MONITORING OF THE ENDANGERED HAWAIIAN MONK SEAL. J Wildl Dis
43: 229-241
[Abstract]
[Full Text]
-
Masala, G., Porcu, R., Daga, C., Denti, S., Canu, G., Patta, C., Tola, S.
(2007). Detection of pathogens in ovine and caprine abortion samples from sardinia, italy, by PCR. jvdi
19: 96-98
[Abstract]
[Full Text]
-
Furrows, S J, Hartley, J C, Bell, J, Silver, N, Losseff, N, Stevenson, S, Chapman, M, Thompson, E J, Ridgway, G L, Giovannoni, G
(2004). Chlamydophila pneumoniae infection of the central nervous system in patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry
75: 152-154
[Abstract]
[Full Text]